Day 2: Saturday, June 8th, 2024 (AST)

08:00 - 08:30

Registration

Session 4 - Moderators: Dr. Firyal Ibrahim & Dr. Dina Soliman

Time

Topic: MPN and CML continued

Speaker

08:30 - 08:55

JAK2 inhibitor in myelofibrosis current understanding and future perspective

Prof. Mervat Matter

08:55 - 09:25

Myelofibrosis treatment algorithm

Prof. Valentin Garcia

09:25 - 09:55

Management of CML year 2024

Prof. Jeorge Cortez

09:55 - 10:05

Panel Discussion

10:05 - 10:20

Coffee Break

10:20 - 10:40

MPN in pregnancy Best Practice and recommendation management

Dr. Mona Al Rashid

10:40 - 11:00

Thrombosis in MPN current understanding and future perspective

Dr. Fatima Khadada

11:00 - 11:20

Value proposition of innovative treatments in Hematology

Dr. Anas Hamad

11:20 - 11:30

Difficult MPN cases where no guidelines can apply

Dr. Omar Ismail

11:30 - 11:40

Panel Discussion

11:40 - 12:40

Prayer & Lunch

Session 5 - Moderators: Dr. Mohammed Bakr & Dr. Zohair Sharfuddin

Topic: Lymphoma and CLL

12:40 - 01:10

Emerging therapist for CLL current perspective and future directions

Prof. Lydia Scarfo

01:10 - 01:40

Treatment sequencing in CLL

Prof. Martin Trepel

01:40 - 01:55

Bispecific Antibodies and CAR-T Cells: Dueling Immunotherapies for Large B-Cell Lymphomas

Dr. Ruba Taha

01:55 - 02:10

Experiences in the use of novel agents in CLL, what are the challenges

Dr. Salem Alshammari

02:10 - 02:20

Panel Discussion

02:20 - 02:35

CLL diagnosed during pregnancy

Dr. Maria Benkhadra and Dr. Sara El Kourashi

02:35 - 02:50

Emerging infections in CLL

Dr. Farah Jibril and Dr. Afaf Al Battah

02:50 - 03:05

Difficult CLL cases where no guidelines can apply

Dr. Safaa Al Azawi

03:05 - 03:20

Autoimmune manifestation in CLL early management and prognosis

Dr. Afraa Mustafa

03:20 - 03:30

Panel Discussion

03:30 - 04:00

Prayer & Coffee Break

Session 6 - Moderators: Dr. Hisham El-Sabah & Dr. Anas Hamad

Topic: Multiple Myeloma​

04:00 - 04:30

How I treat Myeloma, challenges with new novel agents

Prof. Mohamad Mohty

04:30 - 04:50

Experiences with bispecific antibodies in trials and real life

Prof. Maria Mateos

04:50 - 05:05

Dara-VRD as first line treatment the Qatar experience

Dr. Hesham El Sabah

05:05 - 05:15

Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model, The NCCCR experience

Dr. Rola Ghasoub

05:15 - 05:25

Difficult MM cases where no guidelines can apply

Dr. Kamal Al Aboudi

05:25 - 05:40

Panel Discussion

05:40 - 06:00

Closing Ceremony